Company Profiles

driven by the PitchBook Platform

Chase Pharmaceuticals

Description

Provider of medications for the treatment of neurological and psychiatric diseases. The company focuses on the development of medications for the treatment of Alzheimer's disease.

2007

Founded

M&A

Status

11-50

Employees

M&A

Latest Deal Type

$1B

Latest Deal Amount

$38.2M

Total Amount Raised

Description

Provider of medications for the treatment of neurological and psychiatric diseases. The company focuses on the development of medications for the treatment of Alzheimer's disease.

Website:

www.chasepharmaceuticals.com

Ownership Status

Acquired/Merged (Operating Subsidiary)

Financing Status

Formerly VC-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

1825 K Street Northwest Suite 510 Washington, DC 20006United States +1 (202) 792-4621
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Chase Pharmaceuticals's full profile, request a free trial.

    Chase Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Chase Pharmaceuticals Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Chase Pharmaceuticals Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    John Siebert Ph.DSenior Advisor
    Douglas Ingram JDChief Executive Officer & Board Member
    Thomas Chase MDChief Scientific Officer, Board Member & Co-Founder
    Kathleen Clarence-Smith Ph.DChief Medical Officer & Co-Founder
    John Siebert Ph.D Senior Advisor
    Douglas Ingram JD Chief Executive Officer & Board Member
    Thomas Chase MD Chief Scientific Officer, Board Member & Co-Founder
    Kathleen Clarence-Smith Ph.D Chief Medical Officer & Co-Founder

    Chase Pharmaceuticals Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Douglas Ingram JDChase PharmaceuticalsChief Executive Officer & Board Member000 0000
    Karoly Nikolich Ph.DSelfBoard Member000 0000
    Stephen Cunningham MDSelfBoard Member000 0000
    Thomas Chase MDChase PharmaceuticalsChief Scientific Officer, Board Member & Co-Founder000 0000
    Douglas Ingram JD Chief Executive Officer & Board Member Chase Pharmaceuticals
    Karoly Nikolich Ph.D Board Member Self
    Stephen Cunningham MD Board Member Self
    Thomas Chase MD Chief Scientific Officer, Board Member & Co-Founder Chase Pharmaceuticals
    Request full access to PitchBook